Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: EH....may I suggest reading the following on listing requirements

I will continue to disagree.

R/S on a small corporation like this is the same as losing tremendous profit for the shareholder. I fully understand all of the ramifications of R/S. This stock is not going to $10 yet. The growth by the investor is in the $2- $6 range IMO. When the stock is priced higher than this revenue streams of much greater magnitude will be needed.

In February and March 2006, 500 million shares were traded on PTSC. Right now we trade no more than 20 - 25 million a month. This type of thinking by some that R/S is the way to go is all wet IMO. The only one you are hurting is yourself. It can backfire really quickly and you pay the price in real dollars lost.

Cheers

Share
New Message
Please login to post a reply